This is a StreetInsider.com Premium Only Page

(VYNE) –

Apr 3, 2024 05:08 PM Form 4 VYNE Therapeutics Inc. For: Apr 01 Filed by: Zeronda Tyler

Apr 3, 2024 05:06 PM Form 4 VYNE Therapeutics Inc. For: Apr 01 Filed by: Stuart Iain

Apr 3, 2024 05:04 PM Form 4 VYNE Therapeutics Inc. For: Apr 01 Filed by: Harsch Mutya

Apr 3, 2024 05:03 PM Form 4 VYNE Therapeutics Inc. For: Apr 01 Filed by: Domzalski David

Mar 19, 2024 08:00 AM VYNE Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference

Mar 15, 2024 06:29 AM Form EFFECT VYNE Therapeutics Inc.

Mar 1, 2024 05:17 PM Form S-3 VYNE Therapeutics Inc.

Mar 1, 2024 05:16 PM Form S-8 VYNE Therapeutics Inc.

Mar 1, 2024 04:02 PM Form 10-K VYNE Therapeutics Inc. For: Dec 31

Feb 29, 2024 08:13 AM Form 8-K VYNE Therapeutics Inc. For: Feb 29

Feb 29, 2024 08:00 AM VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update

Feb 27, 2024 08:00 AM VYNE Therapeutics to Present Results of the Phase 1b Trial for VYN201 at the 2024 Global Vitiligo Foundation Annual Scientific Symposium

Feb 21, 2024 08:00 AM VYNE Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

Feb 14, 2024 04:57 PM Form SC 13G/A VYNE Therapeutics Inc. Filed by: CITADEL ADVISORS LLC

Feb 2, 2024 09:42 AM Form SC 13G/A VYNE Therapeutics Inc. Filed by: Soleus Capital Master Fund, L.P.

Jan 10, 2024 08:03 AM VYNE Therapeutics (VYNE) Reports Positive Biomarker Data from Successful Phase 1b Trial of VYN201

Jan 10, 2024 08:00 AM VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo

Jan 3, 2024 05:22 PM Form 4 VYNE Therapeutics Inc. For: Jan 01 Filed by: Zeronda Tyler

Jan 3, 2024 05:21 PM Form 4 VYNE Therapeutics Inc. For: Jan 01 Filed by: Stuart Iain

Jan 3, 2024 05:20 PM Form 4 VYNE Therapeutics Inc. For: Jan 01 Filed by: Harsch Mutya

Jan 3, 2024 05:17 PM Form 4 VYNE Therapeutics Inc. For: Jan 01 Filed by: Domzalski David

Jan 3, 2024 05:15 PM Form 4 VYNE Therapeutics Inc. For: Jan 01 Filed by: Sandoval Elisabeth

Jan 3, 2024 05:13 PM Form 4 VYNE Therapeutics Inc. For: Jan 01 Filed by: LEPORE PATRICK G

Jan 3, 2024 05:12 PM Form 4 VYNE Therapeutics Inc. For: Jan 01 Filed by: Bruno Anthony D

Jan 3, 2024 05:11 PM Form 4 VYNE Therapeutics Inc. For: Jan 01 Filed by: Basta Steven L

Jan 3, 2024 05:09 PM Form 4 VYNE Therapeutics Inc. For: Jan 01 Filed by: BARBARI SHARON

Jan 3, 2024 05:07 PM Form 4 VYNE Therapeutics Inc. For: Jan 01 Filed by: Borowski Christine

Jan 3, 2024 05:02 PM Form 3 VYNE Therapeutics Inc. For: Dec 29 Filed by: Borowski Christine

Jan 3, 2024 08:15 AM Form 8-K VYNE Therapeutics Inc. For: Dec 29

Jan 3, 2024 08:03 AM VYNE Therapeutics (VYNE) Appoints Christine Borowski to its Board

Jan 3, 2024 08:00 AM VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors

Dec 15, 2023 05:11 PM Form 4 VYNE Therapeutics Inc. For: Dec 13 Filed by: Zeronda Tyler

Dec 15, 2023 05:10 PM Form 4 VYNE Therapeutics Inc. For: Dec 13 Filed by: Stuart Iain

Dec 15, 2023 05:09 PM Form 4 VYNE Therapeutics Inc. For: Dec 13 Filed by: Harsch Mutya

Dec 15, 2023 05:08 PM Form 4 VYNE Therapeutics Inc. For: Dec 13 Filed by: Domzalski David

Dec 15, 2023 05:07 PM Form 4 VYNE Therapeutics Inc. For: Dec 13 Filed by: Sandoval Elisabeth

Dec 15, 2023 05:05 PM Form 4 VYNE Therapeutics Inc. For: Dec 13 Filed by: LEPORE PATRICK G

Dec 15, 2023 05:04 PM Form 4 VYNE Therapeutics Inc. For: Dec 13 Filed by: Bruno Anthony D

Dec 15, 2023 05:03 PM Form 4 VYNE Therapeutics Inc. For: Dec 13 Filed by: Basta Steven L

Dec 15, 2023 05:02 PM Form 4 VYNE Therapeutics Inc. For: Dec 13 Filed by: BARBARI SHARON

Dec 13, 2023 04:36 PM Form S-8 VYNE Therapeutics Inc.

Dec 13, 2023 04:00 PM Form 8-K VYNE Therapeutics Inc. For: Dec 11

Dec 4, 2023 04:31 PM Form 4 VYNE Therapeutics Inc. For: Nov 30 Filed by: Domzalski David

Nov 24, 2023 06:02 AM Form EFFECT VYNE Therapeutics Inc.

Nov 22, 2023 04:08 PM Form 424B3 VYNE Therapeutics Inc.

Nov 17, 2023 05:03 PM Form 4 VYNE Therapeutics Inc. For: Nov 15 Filed by: LEPORE PATRICK G

Nov 16, 2023 04:31 PM Form D VYNE Therapeutics Inc.

Nov 13, 2023 04:43 PM Form SC 13G VYNE Therapeutics Inc. Filed by: CITADEL ADVISORS LLC

Nov 13, 2023 04:39 PM VYNE Therapeutics (VYNE) Announces 39.27M Share Offering by Selling Stockholders

Nov 13, 2023 04:31 PM Form S-3 VYNE Therapeutics Inc.